Could a diabetes drug also mend hearts? new study in kazakhstan investigates
Disease control
Ongoing
This study tests a dual GIP/GLP-1 drug (a type of diabetes medication) in 120 adults in Kazakhstan who have both chronic heart failure and type 2 diabetes. Participants take the drug for 40 weeks and have regular heart tests, blood work, and genetic checks. The goal is to see if …
Phase: NA • Sponsor: Nazarbayev University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC